Anidulafungin Vicuron.
作者信息
Martin-Mazuelos Estrella
机构信息
Servicio de Microbiologica Clinica, Hospital Universitario de Valme, Seville, Spain.
出版信息
IDrugs. 2003 Oct;6(10):980-6.
PMID:14534856
Abstract
Anidulafungin, a 1,3-beta-glucan synthesis inhibitor and the pentyloxyterphenyl side chain derivative of echinocandin B, is being developed by Vicuron Pharmaceuticals Inc, under license from Eli Lilly & Co, for the potential treatment of fungal infection.
摘要
Zotero 插件